Global health linkage

by Tim Siegenbeek van Heukelom - 14 October 2010 8:48AM

  • China has announced support to sub-Saharan Africa in its fight against snail fever (Schistosomiasis). With some 180 million people infected in sub-Saharan Africa, it is only second to malaria as the key parasitic disease causing public health problems.  
  • Mental health is increasingly discussed in developed countries and finding its place in public health policy — take, for instance, the Australian Headspace or the recent RUOK?Day to prevent suicide. Yet according to the WHO, in developing countries, some 75 percent of sufferers are left untreated, fuelled by a lack of knowledge, social stigma, neglect and lack of funding.
  • Earlier this week the world's first clinical trial for stem cell therapy commenced. Now the world has to wait and see if stem cell therapy can live up to the high expectations of curing many of the so far untreatable chronic diseases and conditions.
Australia in the Asian Century

An Interpreter feature examining the themes of the Gillard Government’s ‘Australia in the Asian Century’ White Paper. Click here to see every post published in this series.

Email Digest  

To receive a weekly digest of ‘Australia in the Asian Century’ posts from The Interpreter via email, enter your email address:

Receive a weekly digest ->

Preview   |   Powered by FeedBlitz

Selected Interpreter posts also appear in:

 
Business Spectator Caing online The Diplomat
 

Keep up-to-date with The Interpreter through:

iPhone App   iPhone App

RSS Feed   The Interpreter RSS Feed

Email Digest  

To receive a digest of posts from The Interpreter via email, enter your email address:

Receive a daily digest ->
Receive a weekly digest ->

Preview   |   Powered by FeedBlitz

Interpreting the Aid Review

This is the archive of a Lowy Institute blog which ran from January to April of 2011. It was published to debate the Gillard Government's independent aid review, which was then in its research and consultation phase. We offer this archive as a service to researchers and the general public.